1. Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer

   • Torhild Veen
   • Arezo Kanani
   • Kjetil Søreide

   Review Open access 01 August 2023 Pages: 3135 - 3147

   

2. Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens

   • Anup Y. Parikh
   • Robert Masi
   • James C. Yang

   Research Open access 27 June 2023 Pages: 3149 - 3162

   

3. Revealing the impact of CD70 expression on the manufacture and functions of CAR-70 T-cells based on single-cell transcriptomics

   • Jiali Cheng
   • Yuyan Zhao
   • Xiaojian Zhu

   Research 29 June 2023 Pages: 3163 - 3174

   

4. Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

   • Jun Takei
   • Yuko Kamata
   • Yasuharu Akasaki

   Research Open access 29 June 2023 Pages: 3175 - 3189

   

5. CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer

   • Peiwei Yang
   • Fan Yu
   • Juan Zhang

   Research 07 July 2023 Pages: 3191 - 3202

   

6. DLGAP5 promotes gallbladder cancer migration and tumor-associated macrophage M2 polarization by activating cAMP

   • Jie Huang
   • Mengyao Zheng
   • Daguang Tian

   Research 08 July 2023 Pages: 3203 - 3216

   

7. Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors

   • Fabrizio Nelli
   • Diana Giannarelli
   • Enzo Maria Ruggeri

   Research 10 July 2023 Pages: 3217 - 3228

   

8. SIGLEC10⁺ macrophages drive gastric cancer progression by suppressing CD8⁺ T cell function

   • Yixian Guo
   • Shouyu Ke
   • Hong Lu

   Research 11 July 2023 Pages: 3229 - 3242

   

9. Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2

   • Zhaojun Duan
   • Zhen Li
   • Yunping Luo

   Research 12 July 2023 Pages: 3243 - 3257

   

10. Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencing

    • Liling Huang
    • Ning Lou
    • Yuankai Shi

    Research 17 July 2023 Pages: 3259 - 3277

    

11. Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma

    • Paola Lasso
    • Laura Rojas
    • Susana Fiorentino

    Research Open access 18 July 2023 Pages: 3279 - 3292

    

12. Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy

    • Siqi Xiong
    • Wenqiang Zhu
    • Daya Luo

    Research 18 July 2023 Pages: 3293 - 3307

    

13. Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells

    • Marion Grard
    • Mohamed Idjellidaine
    • Jean-François Fonteneau

    Research 19 July 2023 Pages: 3309 - 3322

    

14. Good manufacturing practice production of CD34⁺ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia

    • P. K. J. D. de Jonge
    • P. M. M. van Hauten
    • H. Dolstra

    Research Open access 21 July 2023 Pages: 3323 - 3335

    

15. Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events

    • Anna Jokimäki
    • Henna Hietala
    • Outi Kuittinen

    Research Open access 24 July 2023 Pages: 3337 - 3347

    

16. Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment

    • Maria del Mar Maldonado
    • Jeffrey Schlom
    • Duane H. Hamilton

    Research Open access 28 July 2023 Pages: 3349 - 3362

    

17. Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps

    • Luca Modestino
    • Leonardo Cristinziano
    • Maria Rosaria Galdiero

    Research Open access 31 July 2023 Pages: 3363 - 3376

    

18. Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection

    • Julien Balzeau
    • Anindita Ravindran
    • Satoko Matsueda

    Brief Report 19 July 2023 Pages: 3377 - 3385

    

19. Immune checkpoint inhibitor treatment of brain metastasis associated with a less invasive growth pattern, higher T-cell infiltration and raised tumor ADC on diffusion weighted MRI

    • Rasheed Zakaria
    • Michael D. Jenkinson
    • Philip S. Rudland

    Brief Report Open access 21 July 2023 Pages: 3387 - 3393

    

20. Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1

    • Wenjie Li
    • Wei Wang

    Brief Report 27 July 2023 Pages: 3395 - 3399

    

21. Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer

    • Jiannan Chen
    • Jianhua Hu
    • Zhigang Guo

    Correction 14 August 2023 Pages: 3401 - 3403